PubMed search result set – methylene blue treatment case reports in breast cancer (2026)

Peer-Reviewed Study · US National Library of Medicine (PubMed) · November 21, 2026

US National Library of Medicine (PubMed), 2026-11-21: Negative result – none found: the PubMed case-report set for methylene blue in breast cancer (15 records) consists of adverse dye reactions, sentinel-node mapping complications, colour-change reports, diagnostic localisation procedures and one ifosfamide toxicity report; none is a treatment case report of tumour shrinkage on methylene blue with high-dose vitamin C and dietary change.

US National Library of Medicine (PubMed), 2026-11-21: Negative result – none found: the PubMed case-report set for methylene blue in breast cancer (15 records) consists of adverse dye reactions, sentinel-node mapping complications, colour-change reports, diagnostic localisation procedures and one ifosfamide toxicity report; none is a treatment case report of tumour shrinkage on methylene blue with high-dose vitamin C and dietary change. C10 negative search record (breast anecdote). Query: methylene blue[tiab] AND breast neoplasms[MeSH Terms] AND (case reports[pt] OR case report[tiab]) – 15 records, all reviewed by title. Access date 2026-11-21, page undated. Qwen reproduced 15 records via esearch. No treatment case report matching the source's 62-year-old woman with over 70% shrinkage on MB, high-dose vitamin C and diet. Written as SOURCE NOT FOUND, not as a finding of falsity. Study type: other.